Tianjin Caps Retail Prices Of 14 Drugs And Five Diagnostic Services
This article was originally published in PharmAsia News
Tianjin has announced mandatory maximum retail prices for 14 drugs in 19 dosages, and five diagnostic services, effective July 22.
You may also be interested in...
The UK’s CMA has reiterated its belief that Advanz Pharma charged excessive and unfair prices for liothyronine in the UK, following a separate ruling that provided detailed guidance on how such matters should be evaluated.
UK probiotics specialist Optibiotix' CEO Stephen O'Hara speaks exclusively to HBW Insight about the firm's growth ambitions, which have not been held back by the coronavirus pandemic.
The granting of fast-track status is a clear signal that the US FDA wants to maintain its high standards of drug and vaccine appraisal.